FindTrial
Sign In

EFFECT OF AYURVEDA IMMUNO-MODULATOR DRUGS on HEALTH OF CORONA WARRIORS

A Cross Sectional Study To Observe The Health Status Of Personnels Engaged In Care Of Covid-19 Infected/Suspected Persons And Receiving Ayurveda Immuno-Modulator Drugs In Jodhpur City - CSOSC

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025430
Enrollment
1000
Registered
2020-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dabur India Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Person deployed in quarentine ward Person on hard duty family members of health care personnel willingness to participate in study Taking Ayurveda immunomodulator drugs ( Tab. Maha Sudarshan vati + Tab Samshamani Vati + Tab. Haridra

Exclusion criteria

Exclusion criteria: Person below 18 yrs & above 65 yrs Preganant women Any medical condition for which the person is recieing any immunosupressive medicine Known case of malignancy

Design outcomes

Primary

MeasureTime frame
To boost immunity of engaged person in care of COVID-19 infected/ suscpected casesTimepoint: 15 days—

Secondary

MeasureTime frame
To maintain healthy status of engaged person in care of COVID-19 infected/ suscpected cases-15 daysTimepoint: 15 DAYS—

Countries

India

Contacts

Public ContactDr Prem Prakash Vyas

Dr S R Rajasthan Ayurved University

drppvyas@gmail.com9414351871

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026